Stockscreener 앱 받기
4.22
1.20%
0.05
전일 마감가:
$4.17
열려 있는:
$4.23
하루 거래량:
136.27K
Relative Volume:
0.48
시가총액:
$238.28M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-2.8133
EPS:
-1.5
순현금흐름:
$-46.21M
1주 성능:
-12.08%
1개월 성능:
-5.38%
6개월 성능:
+33.97%
1년 성능:
-22.43%
1일 변동 폭
$4.15
$4.32
1주일 범위
$4.06
$4.8887
52주 변동 폭
$2.20
$6.16
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.22 | 235.46M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 개시 | TD Cowen | Buy |
| 2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO - Defense World
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Retail Trends: Does PNTG have strong fundamentalsQuarterly Trade Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Support Test: Is Orchestra BioMed Holdings Inc stock a contrarian buyQuarterly Performance Summary & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Retail Trends: Should value investors consider Orchestra BioMed Holdings Inc - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
Orchestra BioMed Holdings, Inc. to Receive Proceeds from Vivasure Acquisition - TradingView — Track All Markets
Early bet on vessel-closure patch could bring this firm $21M windfall - Stock Titan
Assessing Orchestra BioMed Hldgs: Insights From 4 Financial Analysts - Benzinga
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap touched US$251m last week, benefiting both retail investors who own 41% as well as institutions - Sahm
Can Orchestra BioMed Holdings Inc. stock continue upward trendForecast Cut & Long-Term Growth Portfolio Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock rebound after recent weakness2025 Historical Comparison & Weekly Watchlist of Top Performers - Улправда
Published on: 2026-01-09 01:26:31 - Улправда
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Update & Daily Chart Pattern Signal Reports - ulpravda.ru
Is Orchestra BioMed Holdings Inc. stock a safe buy before earningsBreakout Watch & Daily Profit Focused Stock Screening - Улправда
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Orchestra BioMed (NASDAQ:OBIO) Shares Up 0.2% – Here’s Why - Defense World
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs - Insider Monkey
Orchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025 - MSN
Orchestra BioMed Grants New Hire Stock Options as Clinical Programs Advance - MSN
What drives Orchestra BioMed Holdings Inc stock priceEarnings Beat Highlights & Receive Monthly Expert Trading Blueprints - earlytimes.in
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to NASDAQ Biotechnology Index - marketscreener.com
Why Orchestra BioMed Holdings Inc. stock is in analyst buy zone2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Buyout Rumor: Can Orchestra BioMed Holdings Inc. stock rebound after recent weaknessPortfolio Gains Summary & Capital Protection Trade Alerts - Улправда
What dividend safety score for Orchestra BioMed Holdings Inc. stockWeekly Stock Recap & AI Based Buy/Sell Signal Reports - DonanımHaber
S P Trends: Is Orchestra BioMed Holdings Inc stock a safe buy before earningsQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Orchestra BioMed Holdings Inc. stock is favored by top institutionsRisk Management & Growth Focused Investment Plans - Улправда
Will Orchestra BioMed Holdings Inc. stock maintain growth storyDollar Strength & Verified High Yield Trade Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock deliver consistent earnings growthMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - Улправда
How Orchestra BioMed Holdings Inc. stock performs in high volatility marketsJuly 2025 Chart Watch & Growth Focused Stock Pick Reports - bollywoodhelpline.com
Weekly Trades: What dividend safety score for Orchestra BioMed Holdings Inc stockPortfolio Risk Report & Long Hold Capital Preservation Tips - moha.gov.vn
Chmn Hochman Surrenders 43,638 Of Orchestra BioMed Holdings Inc [OBIO] - TradingView — Track All Markets
Orchestra BioMed Holdings, Inc. (OBIO) CFO has 8,670 shares withheld for taxes - Stock Titan
Orchestra BioMed (OBIO) CEO details RSU-related tax share withholding by insider - Stock Titan
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Analysts at TD Cowen - Defense World
TD Cowen Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio - Investing.com Nigeria
TD Cowen Initiates Orchestra BioMed Holdings at Buy With $15 Price Target - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Orchestra BioMed and Medtronic Unveil Promising Hypertension Therapy Advances - Zenopa
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - Investing News Network
Orchestra BioMed announces AVIM Therapy and Virtue SAB Program presentations at ICI Meeting - marketscreener.com
Orchestra BioMed and Medtronic Leadership to Present on Strategic Collaboration for AVIM Therapy at 2025 Innovation in Cardiology Intervention Meeting - Quiver Quantitative
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements - MSN
What insider trading reveals about Orchestra BioMed Holdings Inc. stockShort Setup & AI Powered Market Trend Analysis - Newser
Orchestra BioMed Enters New Agreement with Terumo for Virtue SAB Device - globallegalchronicle.com
Wall Street Recap: Can Orchestra BioMed Holdings Inc. stock deliver consistent earnings growth2025 Macro Impact & Weekly High Return Stock Forecasts - moha.gov.vn
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):